ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
宜明昂科-B
11.800
-0.530
-4.30%
手动刷新
成交量:
174.54万
成交额:
2,057.75万
市值:
48.06亿
市盈率:
-12.94
高:
12.400
开:
12.340
低:
11.610
收:
12.330
52周最高:
15.660
52周最低:
3.210
股本:
4.07亿
香港流通股本:
3.96亿
量比:
0.73
换手率:
0.44%
股息:
- -
股息率:
- -
每股收益(LYR):
-0.912
净资产收益率:
-44.38%
总资产收益率:
-21.43%
市净率:
6.50
市盈率(LYR):
-12.94
市销率:
55.48
数据加载中...
总览
公司
新闻
公告
【爱建医药】创新药主线强势回归,关注BigPharma管线价值重估
爱建证券研究所
·
07/22
宜明昂科-B盘中异动 股价大跌5.45%
市场透视
·
07/21
医药行业周报:创新药主线强势回归 关注BIGPHARMA管线价值重估
爱建证券
·
07/21
宜明昂科-B盘中异动 股价大涨5.01%报10.280港元
市场透视
·
07/17
宜明昂科-B07月15日主力净流入850.1万元 散户资金抛售
市场透视
·
07/15
宜明昂科-B盘中异动 早盘大幅下跌5.10%
市场透视
·
07/14
宜明昂科-B盘中异动 股价大跌5.04%报10.920港元
市场透视
·
07/11
投资笔记:宜明昂科CD47全球领跑者
港股投研所
·
07/11
宜明昂科-B07月09日主力净流出7.4万元 散户资金买入
市场透视
·
07/09
宜明昂科-B盘中异动 股价大跌5.21%
市场透视
·
07/07
医药行业周报:商保目录将于年内落地 创新药产业出海获得政策支持
爱建证券有限责...
·
07/07
宜明昂科-B涨4% IMM2510获FDA批准IND申请
DoNews
·
07/04
港股异动 | 宜明昂科-B(01541)逆市涨超7% IMM2510/AXN-2510获FDA批准IND申请
智通财经
·
07/04
宜明昂科-B07月03日获主力加仓120.4万元
市场透视
·
07/03
宜明昂科-B(01541):IMM2510/AXN-2510获美国FDA批准IND申请
智通财经
·
07/02
宜明昂科-B盘中异动 早盘快速上涨5.00%
市场透视
·
07/02
宜明昂科-B(01541):付大伟及Kendall Arthur Smith获委任为提名委员会成员
智通财经
·
06/30
宜明昂科-B盘中异动 股价大涨5.42%报11.660港元
市场透视
·
06/30
医药行业周报:关注BD出海催化和商保支付增量
爱建证券有限责...
·
06/30
宜明昂科-B06月27日遭主力抛售1131.5万元
市场透视
·
06/27
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/01541/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"宜明昂科-B","latestPrice":11.8,"timestamp":1756195699002,"preClose":12.33,"halted":0,"volume":1745400,"delay":0,"floatShares":396277305,"shares":407307695,"eps":-0.9121868239993135,"marketStatus":"已收盘","change":-0.53,"latestTime":"08-26 16:08:19","open":12.34,"high":12.4,"low":11.61,"amount":20577460,"amplitude":0.064071,"askPrice":11.8,"askSize":200,"bidPrice":11.75,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-0.9121868239993135,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756258200000},"marketStatusCode":5,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":12.33,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.726778,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":396277305,"roa":"-21.43%","roe":"-44.38%","lyrEps":-0.912187,"volumeRatio":0.726778,"shares":407307695,"dividePrice":0,"high":12.4,"amplitude":0.064071,"preClose":12.33,"low":11.61,"week52Low":3.21,"pbRate":"6.50","psRate":"55.48","week52High":15.66,"institutionHeld":0,"latestPrice":11.8,"committee":0.818182,"eps":-0.9121868239993135,"divideRate":0,"volume":1745400,"delay":0,"ttmEps":-0.9121868239993135,"open":12.34,"prevYearClose":5.16,"prevWeekClose":12.02,"prevMonthClose":11.02,"prevQuarterClose":12,"fiveDayClose":12.96,"twentyDayClose":11.76,"sixtyDayClose":14.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"盘后","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2025-08-25","current":-14.555161,"percent":0.328542,"low":-30.003263,"twenty":-22.665631,"median":-13.01303,"eighty":-6.054191,"high":-2.993766,"avg":-13.617797,"sd":7.665432,"marketCap":5022103879},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555},{"date":"2025-05-16","current":-8.311097,"twenty":-24.799485,"median":-12.12195,"eighty":-5.751942,"marketCap":2843007711},{"date":"2025-05-23","current":-11.289802,"twenty":-24.776462,"median":-11.940532,"eighty":-5.771038,"marketCap":3873496179},{"date":"2025-05-30","current":-15.223569,"twenty":-24.763734,"median":-11.970101,"eighty":-5.797425,"marketCap":5246123111},{"date":"2025-06-06","current":-16.623143,"twenty":-24.617548,"median":-12.331836,"eighty":-5.827424,"marketCap":5743038499},{"date":"2025-06-13","current":-15.603079,"twenty":-24.258649,"median":-12.701975,"eighty":-5.862056,"marketCap":5392753881},{"date":"2025-06-20","current":-14.878015,"twenty":-24.00727,"median":-12.82804,"eighty":-5.90109,"marketCap":5132076957},{"date":"2025-06-27","current":-13.023121,"twenty":-23.933348,"median":-12.837907,"eighty":-5.91626,"marketCap":4504823106},{"date":"2025-07-04","current":-14.906416,"twenty":-23.89321,"median":-12.895238,"eighty":-5.935244,"marketCap":5156515418},{"date":"2025-07-11","current":-12.022018,"twenty":-23.818294,"median":-12.972072,"eighty":-5.957179,"marketCap":4154538489},{"date":"2025-07-18","current":-12.975089,"twenty":-23.597552,"median":-12.895238,"eighty":-5.971632,"marketCap":4480384645},{"date":"2025-07-25","current":-12.316929,"twenty":-23.410778,"median":-12.839078,"eighty":-5.984465,"marketCap":4268584643},{"date":"2025-08-01","current":-12.109688,"twenty":-23.260279,"median":-12.895238,"eighty":-5.992729,"marketCap":4170830796},{"date":"2025-08-08","current":-13.046774,"twenty":-23.142239,"median":-12.972072,"eighty":-6.013995,"marketCap":4504823106},{"date":"2025-08-15","current":-15.594562,"twenty":-23.052783,"median":-12.982136,"eighty":-6.023266,"marketCap":5376461574},{"date":"2025-08-22","current":-14.245172,"twenty":-22.717488,"median":-13.011166,"eighty":-6.052989,"marketCap":4895838493},{"date":"2025-08-25","current":-14.555161,"twenty":-22.665631,"median":-13.01303,"eighty":-6.054191,"marketCap":5022103879}],"updateTime":1756194219268},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553283847","title":"【爱建医药】创新药主线强势回归,关注BigPharma管线价值重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2553283847","media":"爱建证券研究所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553283847?lang=zh_cn&edition=fundamental","pubTime":"2025-07-22 09:23","pubTimestamp":1753147434,"startTime":"0","endTime":"0","summary":"WEEKLY REPORT创新药主线强势回归,关注BigPharma管线价值重估-爱建生物医药行业周报-本报告发布于2025年07月21日投资要点:医药板块跑赢沪深300,创新药再度强势回归。创新药主线强势回归、关注BigPharma管线价值重估。创新药再度领涨,仅线下药店回调。本周创新药出海主线强势回归,我们看好的PD-1双抗、ADC出海核心赛道均有亮眼表现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722095530a6b97362&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722095530a6b97362&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2417539215.USD","LU2462157665.USD","688520","LU1829250122.USD","688131","01541","09926","BK4139","02696","BK4585","LU2236285917.USD","06821","LU0320765992.SGD","SBHMY","688133","BK4505","01177","BK4588","LU0109394709.USD","BK4568","688062","01877","688301","603259","688114","SVA","01276","LU0889565916.HKD","LU2456880835.USD","TIL","688331","AZN","688293","09606","688180","BK4007","688105","01093","02268","02359","600276","02157","688271","09995"],"gpt_icon":0},{"id":"2553944732","title":"宜明昂科-B盘中异动 股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553944732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553944732?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 09:44","pubTimestamp":1753062242,"startTime":"0","endTime":"0","summary":"2025年07月21日早盘09时44分,宜明昂科-B股票出现异动,股价快速下跌5.45%。截至发稿,该股报10.400港元/股,成交量44.96万股,换手率0.11%,振幅5.64%。宜明昂科-B股票所在的生物技术行业中,整体跌幅为0.48%。其相关个股中,瑞科生物-B、三叶草生物-B、华昊中天医药-B涨幅较大,振幅较大的相关个股有三叶草生物-B、北海康成-B、圣诺医药-B,振幅分别为9.47%、9.46%、8.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072109440297addd86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072109440297addd86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2553932471","title":"医药行业周报:创新药主线强势回归 关注BIGPHARMA管线价值重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2553932471","media":"爱建证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553932471?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 00:00","pubTimestamp":1753027200,"startTime":"0","endTime":"0","summary":"医药板块本周+4.00%,排名2/31,跑赢沪深300 指数,创新药再度强势回归。创新药主线强势回归、关注BigPharma 管线价值重估。本周创新药出海主线强势回归,我们看好的PD-1 双抗、ADC 出海核心赛道均有亮眼表现。中小市值创新药在小核酸、AI 医疗和其他新概念的催化下表现活跃,同时,传统大药企也迎来了管线价值重估带来的估值提升。中国生物制药:5 亿美元收购礼新医药,关注后续催化。收购完成后,礼新医药将成为中国生物制药全资子公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721200218a4597b61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721200218a4597b61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","01877","LU0456842615.SGD","01541","603259","LU2328871848.SGD","LU2495084118.USD","02359","09926","02157","02696","09606","600276","688062","LU1969619763.USD","01177","LU1997245177.USD","LU1997244956.HKD","01276","09995","LU2488822045.USD","688331","SBHMY","06821","159992","BK0216","LU1997245094.SGD"],"gpt_icon":0},{"id":"2552428171","title":"宜明昂科-B盘中异动 股价大涨5.01%报10.280港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552428171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552428171?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 09:34","pubTimestamp":1752716077,"startTime":"0","endTime":"0","summary":"2025年07月17日早盘09时34分,宜明昂科-B股票出现异动,股价急速拉升5.01%。截至发稿,该股报10.280港元/股,成交量21.04万股,换手率0.05%,振幅3.06%。资金方面,该股资金流入126.251万港元,流出31.04万港元。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。宜明昂科-B股票所在的生物技术行业中,整体涨幅为1.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717093437a6ae831d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717093437a6ae831d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2551577441","title":"宜明昂科-B07月15日主力净流入850.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2551577441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551577441?lang=zh_cn&edition=fundamental","pubTime":"2025-07-15 16:15","pubTimestamp":1752567340,"startTime":"0","endTime":"0","summary":"07月15日, 宜明昂科-B股价涨0.40%,报收10.00元,成交金额3207.6万元,换手率0.80%,振幅6.53%,量比0.88。宜明昂科-B今日主力资金净流入850.1万元,上一交易日主力净流出159.7万元。该股近5个交易日下跌14.34%,主力资金累计净流入338.3万元;近20日主力资金累计净流出4418.5万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715165325a44be877&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715165325a44be877&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2551920784","title":"宜明昂科-B盘中异动 早盘大幅下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551920784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551920784?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 10:24","pubTimestamp":1752459882,"startTime":"0","endTime":"0","summary":"2025年07月14日早盘10时24分,宜明昂科-B股票出现异动,股价急速下跌5.10%。截至发稿,该股报9.680港元/股,成交量90.82万股,换手率0.23%,振幅5.49%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。宜明昂科-B股票所在的生物技术行业中,整体跌幅为0.65%。其相关个股中,北海康成-B、创胜集团-B、博安生物涨幅较大,振幅较大的相关个股有北海康成-B、创胜集团-B、博安生物,振幅分别为24.32%、15.24%、11.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410244295417c3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410244295417c3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2550069036","title":"宜明昂科-B盘中异动 股价大跌5.04%报10.920港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550069036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550069036?lang=zh_cn&edition=fundamental","pubTime":"2025-07-11 09:52","pubTimestamp":1752198758,"startTime":"0","endTime":"0","summary":"2025年07月11日早盘09时52分,宜明昂科-B股票出现异动,股价大幅跳水5.04%。截至发稿,该股报10.920港元/股,成交量30.98万股,换手率0.08%,振幅4.35%。资金方面,该股资金流入81.2524万港元,流出248.26万港元。宜明昂科-B股票所在的生物技术行业中,整体涨幅为1.98%。其相关个股中,昭衍新药、药明合联、药明康德涨幅较大,振幅较大的相关个股有昭衍新药、药明合联、药明巨诺-B,振幅分别为11.69%、8.00%、7.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711095238a4439ea1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711095238a4439ea1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2550605266","title":"投资笔记:宜明昂科CD47全球领跑者","url":"https://stock-news.laohu8.com/highlight/detail?id=2550605266","media":"港股投研所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550605266?lang=zh_cn&edition=fundamental","pubTime":"2025-07-11 09:20","pubTimestamp":1752196806,"startTime":"0","endTime":"0","summary":"2015年创立宜明昂科担任董事至今。联合阿扎胞苷治疗MDS,其中29例治疗超过6个月,ORR为89.7%,CR达到58.6%。联合PD-1抗体治疗cHL,ORR达69.7%,CR达24.2%,18个月整体生存率达91.6%,安全性及疗效优秀。与来那度胺联用针对复发难治性滤泡淋巴瘤的ORR达88.2%,CR达52.9%。目前公司的CD47融合蛋白总共做了超过300例患者的临床试验,没有观察到严重的安全性风险。初步安全性和有效性结果预计于2025年下半年公布。主要是2024年获得了一项BD授权费首付款1500万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711094304a4439905&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711094304a4439905&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2550827416","title":"宜明昂科-B07月09日主力净流出7.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2550827416","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550827416?lang=zh_cn&edition=fundamental","pubTime":"2025-07-09 16:15","pubTimestamp":1752048940,"startTime":"0","endTime":"0","summary":"07月09日, 宜明昂科-B股价跌3.63%,报收11.16元,成交金额2247.4万元,换手率0.50%,振幅4.66%,量比0.53。宜明昂科-B今日主力资金净流出7.4万元,上一交易日主力净流入42.8万元。该股近5个交易日下跌6.21%,主力资金累计净流出526.4万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出5809.5万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709165930a69f0874&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709165930a69f0874&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2549303380","title":"宜明昂科-B盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549303380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549303380?lang=zh_cn&edition=fundamental","pubTime":"2025-07-07 09:43","pubTimestamp":1751852611,"startTime":"0","endTime":"0","summary":"2025年07月07日早盘09时43分,宜明昂科-B股票出现波动,股价快速下挫5.21%。截至发稿,该股报12.000港元/股,成交量40.92万股,换手率0.10%,振幅5.06%。资金方面,该股资金流入145.855万港元,流出337.024万港元。宜明昂科-B股票所在的生物技术行业中,整体涨幅为0.47%。宜明昂科-B公司简介:宜明昂科生物医药技术(上海)股份有限公司是一家主要从事测试生物技术研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707094331a43ab280&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707094331a43ab280&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2549392405","title":"医药行业周报:商保目录将于年内落地 创新药产业出海获得政策支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2549392405","media":"爱建证券有限责...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549392405?lang=zh_cn&edition=fundamental","pubTime":"2025-07-07 00:00","pubTimestamp":1751817600,"startTime":"0","endTime":"0","summary":"医药板块跑赢沪深300,创新药强势回归。创新药强势回归,中国创新药出海的产业趋势不变。商保创新药目录将于年内落地,创新药产业出海获得政策支持。国家医保局本周公布了2025 年国家医保目录和商保创新药目录的调整方案,商保创新药目录有望在11 月首次落地;同时,医保基金继续加大对于创新药的支付力度,纳入医保的创新药产品的国内市场销售峰值也将随之提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707191558979cf5ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707191558979cf5ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","BK1574","01858","06978","01877","688062","02268","BK1161","01541"],"gpt_icon":0},{"id":"2548355554","title":"宜明昂科-B涨4% IMM2510获FDA批准IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2548355554","media":"DoNews","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548355554?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 12:01","pubTimestamp":1751601662,"startTime":"0","endTime":"0","summary":"北京时间2025年7月4日,宜明昂科-B(01541)午前股价上涨4.27%,报12.70港元。公司与Instil联合宣布,IMM2510/AXN-2510已获美国FDA批准新药临床试验(IND)申请。该药物将用于治疗复发性/难治性实体肿瘤患者,并计划于2025年底前启动1b/2期试验,评估其安全性、疗效及药代动力学。同时,IMM2510/AXN-2510联合化疗治疗非小细胞肺癌的2期研究数据预计将于2025年下半年公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070412034295360461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070412034295360461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2548334972","title":"港股异动 | 宜明昂科-B(01541)逆市涨超7% IMM2510/AXN-2510获FDA批准IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2548334972","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548334972?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 09:35","pubTimestamp":1751592948,"startTime":"0","endTime":"0","summary":"消息面上,宜明昂科-B发布公告,本公司与Instil共同欣然宣布,Instil已自美国食品药品监督管理局取得 IMM2510/AXN-2510的新药临床试验批准。Instil预计将在2025年底前启动IMM2510/AXN-2510作为单药治疗复发性/难治性实体肿瘤患者的1b/2期试验。该试验旨在评估IMM2510/AXN-2510在实体肿瘤患者中的安全性、疗效、药物代谢动力学及药效学。此外,正在中国进行的IMM2510/AXN-2510联合化疗治疗一线非小细胞肺癌的2期研究数据预计将于2025年下半年由本公司公布。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1313852.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 宜明昂科-B(01541)逆市涨超7% IMM2510/AXN-2510获FDA批准IND申请","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2548808846","title":"宜明昂科-B07月03日获主力加仓120.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548808846","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548808846?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 16:15","pubTimestamp":1751530540,"startTime":"0","endTime":"0","summary":"07月03日, 宜明昂科-B股价涨2.18%,报收12.18元,成交金额2918.1万元,换手率0.61%,振幅6.04%,量比0.43。宜明昂科-B今日主力资金净流入120.4万元,连续3日净流入,上一交易日主力净流入2.6万元。该股近5个交易日下跌8.56%,主力资金累计净流出3042.5万元;近20日主力资金累计净流出4433.0万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703170404a72c5f2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703170404a72c5f2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2548893877","title":"宜明昂科-B(01541):IMM2510/AXN-2510获美国FDA批准IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2548893877","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548893877?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 18:06","pubTimestamp":1751450815,"startTime":"0","endTime":"0","summary":"智通财经APP讯,宜明昂科-B(01541)发布公告,本公司与Instil共同欣然宣布,Instil已自美国食品药品监督管理局(FDA)取得 IMM2510/AXN-2510的新药临床试验(IND)批准。Instil预计将在2025年底前启动 IMM2510/AXN-2510作为单药治疗复发性/难治性实体肿瘤患者的1b/2期试验。该试验旨在评估IMM2510/AXN-2510在实体肿瘤患者中的安全性、疗效、药物代谢动力学及药效学。此外,正在中国进行的IMM2510/AXN-2510联合化疗治疗一线非小细胞肺癌(NSCLC)的2期研究数据预计将于2025年下半年由本公司公布。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1313109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2548830230","title":"宜明昂科-B盘中异动 早盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548830230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548830230?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 09:32","pubTimestamp":1751419956,"startTime":"0","endTime":"0","summary":"2025年07月02日早盘09时32分,宜明昂科-B股票出现异动,股价急速拉升5.00%。截至发稿,该股报12.600港元/股,成交量46.1万股,换手率0.12%,振幅5.83%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。宜明昂科-B股票所在的生物技术行业中,整体涨幅为0.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070209323697969f93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070209323697969f93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2547863013","title":"宜明昂科-B(01541):付大伟及Kendall Arthur Smith获委任为提名委员会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=2547863013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547863013?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 22:48","pubTimestamp":1751294898,"startTime":"0","endTime":"0","summary":"智通财经APP讯,宜明昂科-B(01541)发布公告,非执行董事付大伟女士及独立非执行董事 Kendall Arthur Smith博士均获委任为董事会提名委员会成员,两者均自2025年6月30日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1312219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2547805840","title":"宜明昂科-B盘中异动 股价大涨5.42%报11.660港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547805840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547805840?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 11:17","pubTimestamp":1751253438,"startTime":"0","endTime":"0","summary":"2025年06月30日早盘11时17分,宜明昂科-B股票出现异动,股价急速拉升5.42%。截至发稿,该股报11.660港元/股,成交量105.1万股,换手率0.27%,振幅6.87%。资金方面,该股资金流入597.012万港元,流出497.124万港元。宜明昂科-B股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,昭衍新药、中国抗体-B、巨子生物涨幅较大,振幅较大的相关个股有昭衍新药、北海康成-B、欧康维视生物-B,振幅分别为15.54%、10.71%、9.20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063011171897941082&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063011171897941082&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2547099099","title":"医药行业周报:关注BD出海催化和商保支付增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2547099099","media":"爱建证券有限责...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547099099?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 00:00","pubTimestamp":1751212800,"startTime":"0","endTime":"0","summary":"医药板块上半周在创新药的带动下出现整体反弹;周四市场对荣昌生物的BD 方案引发争议,创新药板块再次出现回调;周五迈威生物公布两项BD交易,虽然首付款金额均不大,依然表现亮眼。可见,市场对于创新药板块依然有较高的关注度,对于BD 出海的产业催化仍有所期待。Bimagrumab+司美格鲁肽组合治疗肥胖或超重患者,体重下降的92.8%来自脂肪,显著高于司美格鲁肽单药的71.8%,值得注意的是,Bimagrumab 单药组不仅100%的减重来自于脂肪,且瘦体重增加2.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063020135995313e3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063020135995313e3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","688062","01541","BK1161","BK1574"],"gpt_icon":0},{"id":"2546198007","title":"宜明昂科-B06月27日遭主力抛售1131.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546198007","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546198007?lang=zh_cn&edition=fundamental","pubTime":"2025-06-27 16:15","pubTimestamp":1751012134,"startTime":"0","endTime":"0","summary":"06月27日, 宜明昂科-B股价跌6.27%,报收11.06元,成交金额1.1亿元,换手率2.43%,振幅11.36%,量比2.58。宜明昂科-B今日主力资金净流出1131.5万元,连续3日净流出,上一交易日主力净流出2043.4万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为35.71%,平均跌幅为5.16%。该股近5个交易日下跌12.22%,主力资金累计净流出3374.2万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出4840.5万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627172651a4c0dd11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627172651a4c0dd11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":191,"code":"91000000","status":"200"}]}}